Humic acid–loaded pHEMA cryogels as an antimicrobial platform for MRSA-infected diabetic foot: in vitro, in vivo, and molecular docking studies
Rattachement africain : tr. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Abstract Diabetic foot infections complicated by methicillin-resistant Staphylococcus aureus (MRSA) remain a major clinical challenge due to impaired wound healing and limited effectiveness of conventional antibiotic therapies. In this study, humic acid (HA)–loaded p(HEMA-GMA) cryogels were successfully synthesized and evaluated as a multifunctional wound dressing platform for the treatment of MRSA-infected diabetic foot wounds. The structural and chemical characteristics of the cryogels were confirmed by scanning electron microscopy (SEM) and Fourier transform infrared spectroscopy (FTIR). The HA-loaded cryogels exhibited a high swelling ratio of approximately 97%, indicating excellent exudate absorption capacity. Biocompatibility and hemocompatibility assessments demonstrated that the cryogels were safe for biomedical applications. In vitro antibacterial studies revealed that HA2-p(HEMA-GMA) achieved 93.9 ± 0.85% inhibition of MRSA growth based on time-kill kinetics. SEM analyses further confirmed the disruption of MRSA biofilm structures and severe deformation of bacterial morphology. In vivo therapeutic efficacy was evaluated using an MRSA-infected diabetic rat foot wound model, where treatment with HA2-p(HEMA-GMA) resulted in a significant wound area reduction of 94.5 ± 0.7%. Molecular docking analysis provided preliminary insights into potential interactions, showing a favorable binding affinity of humic acid toward the 2 × 3 F protein, with a docking score of − 8.358 kcal/mol. Overall, these findings indicate that HA-loaded p(HEMA-GMA) cryogels effectively modulate the wound microenvironment, suppress bacterial proliferation, and accelerate wound healing under diabetic and infected conditions. This multifunctional cryogel system represents a promising alternative therapeutic strategy for the management of MRSA-infected diabetic foot wounds.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Humic acid–loaded pHEMA cryogels as an antimicrobial platform for MRSA-infected diabetic foot: in vitro, in vivo, and molecular docking studies
- Date Crossref
- 02/05/2026
- Éditeur
- Springer Science and Business Media LLC
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Les institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.